Oppenheimer & Co’s Bio-Techne TECH Stock Holding History

Oppenheimer & Co’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,132	Closed	-$268K	–	1835
2026 Q1	$268K	Sell	5,132 -219	-4%	-$13.1K	﹤0.01%	1442
2025 Q4	$315K	Buy	5,351 +181	+4%	+$11K	﹤0.01%	1257
2025 Q3	$288K	Buy	+5,170	New	+$277K	﹤0.01%	1407

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Oppenheimer & Co's TECH Position: Q2 2026 in Review

Oppenheimer & Co sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 5,132 shares — an estimated $268K sold.

Oppenheimer & Co first reported a position in TECH in Q3 2025 and held it in 3 quarters. The position peaked at $315K in Q4 2025. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Oppenheimer & Co reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
Oppenheimer & Co sold 5,132 Bio-Techne shares in Q2 2026, an estimated $268K.
Oppenheimer & Co first reported a position in Bio-Techne in Q3 2025 and held it in 3 quarters.
Oppenheimer & Co's Bio-Techne position peaked at $315K in Q4 2025.
596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.